Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.67 USD | +2.58% | +1.77% | +172.60% |
Mar. 19 | Avidity Biosciences, Inc. announced that it has received $400.208766 million in funding | CI |
Mar. 15 | Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+172.60% | 1.97B | |
+0.44% | 90.27B | |
+10.00% | 44.05B | |
-16.40% | 31.45B | |
+44.36% | 23.35B | |
-8.10% | 16.72B | |
-25.64% | 15.09B | |
-9.03% | 12.82B | |
-9.37% | 11.95B | |
+98.58% | 7.67B |
- Stock
- Equities
- Stock Avidity Biosciences, Inc. - Nasdaq
- News Avidity Biosciences, Inc.
- Wells Fargo Adjusts Price Target on Avidity Biosciences to $55 From $60, Maintains Overweight Rating